Scopus by Title (Ref)

New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine

Antioxidants

August 2025

Kontoghiorghes G.J.

Open Access

N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment

Pharmaceutics

April 2025

Meadows I.

Open Access

Supplementation of Antioxidants in Chronic Kidney Disease: Clinical Necessity or Wishful Thinking? A Bench to Bedside Translational Research

Current Medicinal Chemistry

2025

Roumeliotis S.

Antioxidants for adults with chronic kidney disease

Cochrane Database of Systematic Reviews

2 November 2023

Colombijn J.M.T.

All Open Access, Green

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties

International Urology and Nephrology

June 2023

Cepaityte D.

Open Access

N-acetylecysteine, a powerful agent in the reinforcement of anti-oxidant profile: A systematic review and dose-response meta-analysis of controlled clinical trials

Clinical Nutrition Espen

April 2023

Mahmoudinezhad M.

The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis

Frontiers in Nutrition

2023

Liu J.

Open Access

The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: A systematic review and meta-analysis of controlled clinical trials

European Journal of Pharmacology

5 October 2020

Faghfouri A.H.

Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology

Expert Opinion on Investigational Drugs

3 July 2019

Kontoghiorghes G.J.

Antioxidant supplementation in renal replacement therapy patients: Is there evidence?

Oxidative Medicine and Cellular Longevity

2019

Liakopoulos V.

Open Access